Raymond Joseph Tesi - 22 Jun 2021 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
President & CEO, Director, 10%+ Owner
Signature
/s/ Raymond J. Tesi
Issuer symbol
INMB
Transactions as of
22 Jun 2021
Net transactions value
$0
Form type
4
Filing time
24 Jun 2021, 18:00:53 UTC
Next filing
09 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option Award $0 +70,663 $0.000000 70,663 22 Jun 2021 Common Stock 70,663 $17.49 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Option represents a right to receive one share of common stock of INmune Bio, Inc.
F2 Options granted pursuant to 2021 Stock Incentive Plan. Twenty-five percent of the Option will vest 12 months from the date of grant and thereafter the remaining unvested Option will become vested and exercisable pro rata on a monthly basis over three (3) years (1/36 per month) until the Option is 100% vested which shall occur on the four-year anniversary of the date of grant.